[HTML][HTML] Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - PloS one, 2022 - journals.plos.org
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

[PDF][PDF] Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - PLoS ONE, 2022 - researchgate.net
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

[HTML][HTML] Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - PLoS ONE, 2022 - ncbi.nlm.nih.gov
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction.

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - Plos one, 2022 - europepmc.org
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction.

Z Lotfollahi, APQ Mello, FAH Fonseca… - PLoS …, 2022 - search.ebscohost.com
Background: Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

[PDF][PDF] Changes in lipoproteins associated with lipid lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - PLOS …, 2022 - repositorio.usp.br
Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with
acute myocardial infarction Page 1 RESEARCH ARTICLE Changes in lipoproteins associated …

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca… - PLoS …, 2022 - ui.adsabs.harvard.edu
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

[PDF][PDF] Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - PLoS ONE, 2022 - scienceopen.com
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

[PDF][PDF] Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction

Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - PLoS ONE, 2022 - repositorio.usp.br
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …